Drug Type Recombinant polypeptide |
Synonyms Chorionic Gonadotropin, LDI 200, LDI-200 |
Target |
Action agonists |
Mechanism LHCGR agonists(Luteinizing hormone/Choriogonadotropin receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |


| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acute Myeloid Leukemia | Phase 3 | - | - | |
| Acute Myeloid Leukemia | Phase 3 | - | - | |
| Acute Myeloid Leukemia | Phase 3 | - | - | |
| Acute Myeloid Leukemia | Phase 3 | - | - | |
| Prostatic Cancer | Phase 3 | - | - | |
| Prostatic Cancer | Phase 3 | - | - | |
| Prostatic Cancer | Phase 3 | - | - | |
| Prostatic Cancer | Phase 3 | - | - |






